A roundup of all the latest news on www.globaluniversityventuring.com for our subscribers.

Big deal: Nightstar shines bright in $800m acquisition
Nightstar Therapeutics, based on Oxford research, stands to receive $800m from Biogen in an acquisition deal that comes a year and a half after completing a $75m IPO.
Imperial internalises tech transfer
ICL will restore internal tech transfer activities from its Imperial White City Incubator, in the process ending its arrangement with commercialisation firm IP Group.
Larter lands at Calgary
Stephen Larter has become…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?